Re-investigation of the concordance of human NAT2 phenotypes and genotypes

This publication has 18 references indexed in Scilit:

• Arylamine N-acetyltransferases and Drug Response
  Pharmacogenomics, 2002
• Pharmacogenetics of the arylamine N-acetyltransferases
  The Pharmacogenomics Journal, 2002
• Occupational history and genetic N-acetyltransferase polymorphism of urothelial cancer patients in Leverkusen, Germany
  Scandinavian Journal of Work, Environment & Health, 1996
• NAT2*12A (803A???G) codes for rapid arylamine N-acetylatioii in humans
  Pharmacogenetics, 1996
• Preliminary phenotypic map of chromosome 4p16 based on 4p deletions
  American Journal of Medical Genetics, 1995
• Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes
  Human Molecular Genetics, 1994
• SHORT COMMUNICATION: Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans
  Carcinogenesis: Integrative Cancer Research, 1993
• Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants
  Pharmacogenetics, 1992
• Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
  Pharmacogenetics, 1992
• A simple test for acetylator phenotype using caffeine.
  British Journal of Clinical Pharmacology, 1984